Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.648 USD | -0.46% | -1.93% | -3.01% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 22M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.86
x | P/E ratio 2025 * |
-0.99
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.86% |
Latest transcript on Lisata Therapeutics, Inc.
1 day | -0.46% | ||
1 week | -1.93% | ||
Current month | -15.13% | ||
1 month | -16.55% | ||
3 months | -6.77% | ||
6 months | +28.53% | ||
Current year | -3.01% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.648 | -0.46% | 4,678 |
24-04-25 | 2.66 | -6.01% | 6,093 |
24-04-24 | 2.83 | +6.79% | 9,625 |
24-04-23 | 2.65 | -0.75% | 13,395 |
24-04-22 | 2.67 | -1.11% | 1,894 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.01% | 22M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LSTA Stock